Considering the slow tumor targeting of large hurA33 and the low affinity of small A33scFv, it is better to develop divalent diabodies, minibodies, or scFv-Fc antibodies against GPA33 as imaging tools. The gene discussed is GPA33; the disease is neoplasm.